Klinisk dokumentation
Dokumentation av kontaminering
Klicka här för att läsa mer...
Dokumentation av hälsorisker
Dokumentation av PhaSeal
Klicka här för att läsa mer...

Dokumentation av hälsorisker

1. Valanis B, Vollmer WM, Steele P. Occupational Exporsure to Antineoplastic Agents: Self-Reported Miscarriages and Stillbirths Among Nurses and Pharmacists. J Occu Envir Med Vol 41 No. 8, AUG 1999, 632-638.
Abstrakt

2. Sessink PJM, Kroese ED, van Kranen HJ, Bos RP. Cancer risk
assessment for health care workers occupationally exposed to cyclophosphamide. Int Arch Occup Environ Health, 1995, 67:317-323.
Abstrakt

3. Hansen J, Olsen JH. Cancer morbidity among Danish Female pharmacy technicians. Scand J Work Environ Health, 1994; 20:22-6.
Abstrakt

4. Valanis B, Vollmer W, Glass A. Acute symptoms associated with antineoplastic drug handling among nurses. Cancer Nursing 16(4): 288-295, 1993.
Abstrakt

5. Skov T, Maarup B, Olsen J et al. Leukaemia and reproductive outcome among nurses handling antineoplastic drugs. Br J Ind Med. 1992; 49:855-61.
Abstrakt

6. Selevan SG, Lindbohm M-L, Hornug RW et al. A study of occupational exposure to antineoplastic drugs and fetal loss in nurses. N Engl J Med. 1985; 313:1173-8.
Abstrakt

7. Hemminki K Kyyronen P, Lindlohm ML. Spontaneous abortions and malformations in the offspring of nurses exposed to anaesthetic gases, cytostatic drugs, and other potential hazards in hospitals, based on registered information of outcome. J Epidemiol Community Health. 1985; 39:141-7.
Abstrakt

8. Sotaniemi EA, Sutinen S, Arranto AJ et al. Liver damage in nurses handling cytostatic agents. Acta Med Scand. 1983; 214:181-9.
Abstrakt

9. Peelen S, Roeleveld N, et al. Toxic effects on reproduction in hospital personnel. (Translation by Interverbum, Gothenburg Sweden from original Dutch)

Abstrakt


Disclaimer
Copyright © 2010 Carmel Pharma AB. All rights Reserved                  Global Home